Myeloma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
"Who might be able to join this trial:
- You must have already enrolled in a CAR-T cell therapy study at Froedtert Hospital & the Medical College of Wisconsin.
Who may not be able to join:
- There are no rules that would stop someone from joining this trial, as long as they meet the requirement above.
Important: Always verify eligibility with the trial site directly before applying."
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Nirav Shah, Medical College of Wisconsin
Phone: 414-805-8900
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change from baseline in the incidence of a new malignancy at 5 years.; Change from baseline in the incidence of a new malignancy at 10 years.; Change from baseline in the incidence of a new malignancy at 15 years.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.